Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dienogest vs UAE for Adenomyosis
NCT06719934Phase 1Not yet recruiting
- Sponsor
- Al-Azhar University
- Start
- Jan 2025
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of dienogest in adenomyosis (2 arms), sponsored by Al-Azhar University. Primary endpoint: Evaluation of Adenomyosis-associated symptoms (dysmenorrhea, heavy menstrual bleeding, bulk-related symptoms) at 1 year. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
dienogest
03
Conditions
adenomyosis
Beyond the preview
Go deeper on NCT06719934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06719934.